All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2017-D-1105
Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11--Questions and Answers; Draft Guidance for Industry; Availability
Documents
6
Comments
77
Key Dates
Comment Period OpensJun 21, 2017
Comment Period ClosesMay 16, 2023
Documents
Comment Statistics
Total Comments
77
Keywords
CDER
2013-622
Use of Electronic Records and Electronic
Signatures in Clinical Investigations Under
21 CFR Part 11--Questions and Answers
Draft Guidance for Industry
Availability
OPEN
Data from Regulations.gov